𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum levels of soluble interleukin-2 receptor

✍ Scribed by Yosef Uziel; Bernice R. Krafchik; Brian Feldman; Earl D. Silverman; Laurence A. Rubin; Ronald M. Laxer


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
414 KB
Volume
37
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Soluble interleukin-2 receptor serum lev
✍ Eric Tartour; Laurent Deneux; Veronique Mosseri; Christian Jaulerry; FranΓ§oise B πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

Jose Β΄Rodriguez, M.D. ## RESULTS. At presentation, a relationship was observed between advanced tumor (T) classification and high serum levels of CRP (P Γ… 0.0015) and s-IL-2-R (P Γ΅ Head and

Soluble interleukin-2 receptor serum lev
✍ Rolf-Markus Szeimies; Franziska Rueff; Peter Kaudewitz πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 376 KB πŸ‘ 2 views

Background. In a variety of non-Hodgkin lymphomas, a correlation between soluble interleukin-2 receptor levels (sIL-2R) and clinical stage is demonstrable. In mycosis fungoides (MF), two findings raise the question as to a similar correlation: (1) a proportion of tumor cells express IL-2 receptor an

Serum-soluble interleukin-2 receptor con
✍ Saburo Murakami; Akira Safomi; Kiyoshi Lshida; Hideaki Murai; Moriyuki Mafsuki; πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 369 KB πŸ‘ 2 views

Background. Serum concentrations of soluble interleukin-2 receptor (IL-2R) were found to be high in patients with autoimmune diseases, lung cancer, malignant lymphoma, tuberculosis, and other diseases. Serum-soluble IL-2R was evaluated as a tumor maker in patients with gastric cancer. Methods. Preo

Plasma soluble interleukin-2 receptor le
✍ Erduran, Erol; Aslan, Yakup; Aliyazicioğlu, YΓΌksel; Mocan, Hilal; Gedik, Yusuf πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 63 KB πŸ‘ 2 views

Soluble interleukin-2 receptor (sIL-2R) was measured in the plasma of 31 patients with idiopathic thrombocytopenic purpura (ITP) and 22 normal controls. When thrombocytopenia persisted longer than 6 months, the diagnosis of chronic ITP was made. Twenty patients had acute ITP, 11 patients had chronic